oncology management

Editor's Page

09/06/2016

Winston Wong, PharmD, Editor-in-Chief

One of the core goals of clinical pathways development has always been to make health care more patient-centered. However, a common complaint regarding clinical pathway development is that patients are often left out...

One of...

09/06/2016

Journal of Clinical Pathways

Research in Review

Barriers Predict Nonadherence to Treatment for Early-Stage Breast Cancer

09/06/2016

JCP Editors

Perceived barriers to treatment may predict patient nonadherence to aromatase inhibitors for women with early-stage, estrogen receptor-positive breast cancer, claims a study published in Cancer. While patient...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Active Surveillance Feasible for Some Patients With Kidney Cancer

08/10/2016

JCP Editors

Certain patients with metastatic renal cell carcinoma can (RCC) safely undergo active surveillance before initiating systemic treatment, findings from a study published in The Lancet Oncology show. RCC has a wide...

...

08/10/2016

Journal of Clinical Pathways

Research in Review

Health Insurance Status a Significant Influencer of Cancer Outcomes

08/08/2016

JCP Editors

Two studies published online in the journal Cancer have shown that patients’ health insurance status may impact outcomes following cancer diagnosis. Using population-based data from the Surveillance, Epidemiology,...

Two...

08/08/2016

Journal of Clinical Pathways

Pharma Insights

The Rising Use of Oncology Value Tools By Payers

08/02/2016

Jeremy Schafer, PharmD, MBA

Kellie Rademacher, PharmD

Janet Serluco, MS

Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...

...

08/02/2016

Journal of Clinical Pathways

Conference Preview

Shaping the Pathways of the Future

08/02/2016

JCP Editors

The Inaugural Clinical Pathways Congress September 16-18, 2016; Boston, MA As US expenditures on cancer-related treatments continue to grow, new solutions for managing these costs have increasingly become...

The...

08/02/2016

Journal of Clinical Pathways

Outcomes of a Clinical Pathways Program

08/02/2016

JCP Editors

J Russel Hoverman, MD, PhD, Texas Oncology, next spoke about the performance of clinical pathways in practice. Texas Oncology has used clinical pathways for the last 10 years. In collaboration with Aetna and with US...

J...

08/02/2016

Journal of Clinical Pathways

The Payer Perspective

08/02/2016

JCP Editors

Balancing out the provider perspective was Andrew Allan  Hertler, MD, FACP, New Century Health, who explained why clinical pathways are increasingly being used by payers as a tool for controlling oncology...

...

08/02/2016

Journal of Clinical Pathways

The Oncology Practice Perspective

08/02/2016

JCP Editors

In order to address the oncologist’s perspective on clinical pathways, James N Frame, MD, FACP, Charleston Area Medical Center, talked about some of the concerns that oncology care providers have about using clinical...

In...

08/02/2016

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Annual Meeting

08/02/2016

JCP Editors

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, a session was held on the first day dedicated to the topic of clinical pathways in oncology. The session, titled “Practicing in the Age of...

At the...

08/02/2016

Journal of Clinical Pathways